ScholarIQanswers from OpenAlex & ORCID
Brian Claggett
ResearcherPublications, citations & collaboration network
Brian Claggett is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Brian Claggett have?
ScholarIQindexed works
Brian Claggett has 1,030 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Brian Claggett have?
ScholarIQcitation count
Brian Claggett has 47,993 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Brian Claggett?
ScholarIQh-index
Brian Claggett has an h-index of 103 in OpenAlex.
What is the i10-index of Brian Claggett?
ScholarIQi10-index
Brian Claggett has an i10-index of 509 in OpenAlex.
What is the ORCID of Brian Claggett?
ScholarIQorcid
The ORCID for Brian Claggett is on the source record.
What is the OpenAlex record for Brian Claggett?
ScholarIQopenalex
The OpenAlex for Brian Claggett is on the source record.
What are the most-cited papers on Brian Claggett?
ScholarIQmost cited works
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann, Robin Boineau, Inder S. Anand, Brian Claggett, Nadine Clausell, Akshay S. Desai, Rafael Díaz, Jerome L. Fleg, И. Г. Гордеев, Brian Harty, John F. Heitner, Christopher T. Kenwood, Eldrin F. Lewis, Eileen O’Meara, Jeffrey L. Probstfield, Tamaz Shaburishvili, Sanjiv J. Shah, Scott D. Solomon, Nancy K. Sweitzer, Song Yang, Sonja M. McKinlay
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Brian Claggett, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, Pardeep S. Jhund, Jan Bělohlávek, Chern‐En Chiang, C. Jan Willem Borleffs, Josep Comín‐Colet, Dan Dobreanu, Jarosław Dróżdż, James C. Fang, Marco A. Alcocer‐Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan Janssens, Tzvetana Katova, Masafumi Kitakaze, Béla Merkely, Eileen O’Meara, José Francisco Kerr Saraiva, С. Н. Терещенко, Jorge Thierer, Muthiah Vaduganathan, Orly Vardeny, Subodh Verma, Vinh Pham, Ulrica Wilderäng, Natalia Zaozerska, Erasmus Bachus, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand, Junbo Ge, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Akshay S. Desai, Brian Claggett, Pardeep S. Jhund, S. А. Boytsov, Josep Comín‐Colet, John G.F. Cleland, Hans‐Dirk Düngen, Eva Gonçalvesová, Tzvetana Katova, Jose F. Kerr Saraiva, Małgorzata Lelonek, Béla Merkely, Michele Senni, Sanjiv J. Shah, Jingmin Zhou, Adel R. Rizkala, Jianjian Gong, Victor Shi, Martin Lefkowitz
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Marc A. Pfeffer, Brian Claggett, Susan F. Assmann, Robin Boineau, Inder S. Anand, Nadine Clausell, Akshay S. Desai, Rafael Díaz, Jerome L. Fleg, И. Г. Гордеев, John F. Heitner, Eldrin F. Lewis, Eileen O’Meara, Jean L. Rouleau, Jeffrey L. Probstfield, Tamaz Shaburishvili, Sanjiv J. Shah, Scott D. Solomon, Nancy K. Sweitzer, Sonja M. McKinlay, Bertram Pitt
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Muthiah Vaduganathan, Kieran F. Docherty, Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, John J.V. McMurray, Scott D. Solomon